Intracerebroventricular (ICV) injection of alarin has also been proven to improve depression-like behaviors through the alarin-mediated restoration of UCMS-induced reduction of phospho-mTOR and phospho-4E-BP1 in the prefrontal cortex, hippocampus, hypothalamus, and olfactory bulb. Here, MTOR is linked to depressive symptom measurement.